Premium
Analysis of fluorouracil in human plasma by combined gas‐liquid chromatography mass spectrometry
Author(s) -
CosynsDuyck MarieClaire,
Cruyl Annie A. M.,
De Leenheer André P.,
De Schryver André,
Huys John V.,
Belpaire Frans M.
Publication year - 1980
Publication title -
biomedical mass spectrometry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 121
eISSN - 1096-9888
pISSN - 0306-042X
DOI - 10.1002/bms.1200070205
Subject(s) - chromatography , chemistry , mass spectrometry , dichloromethane , gas chromatography , extraction (chemistry) , gas chromatography–mass spectrometry , derivative (finance) , selected ion monitoring , high performance liquid chromatography , organic chemistry , solvent , financial economics , economics
Fluorouracil in human plasma at a concentration as low as 2 ng ml −1 can be assayed with the use of gas‐liquid chromatography and a multiple ion detector. Fluorouracil is isolated from plasma by anion exchange extraction. The extract is butylated and the derivative obtained extracted into a mixture of cyclohexane + dichloromethane (95:5). An aliquot is submitted to combined gas‐liquid chromatography mass spectrometry. The use of chlorouracil or oxygen‐18 labelled flurouracil as internal standard is discussed. Linearity is proven from 100 μg to 5 ng of fluorouracil per ml plasma. The coefficients of variation are 7.2 and 8.4% for within‐run and between‐run precision, respectively, at the 50 ng ml −1 level. The biological applicability of our procedure is demonstrated by analysing plasma samples obtained at different time intervals from three patients given 1 g of fluorouracil once intravenously and once orally.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom